0001127602-20-030583.txt : 20201204 0001127602-20-030583.hdr.sgml : 20201204 20201204163936 ACCESSION NUMBER: 0001127602-20-030583 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201202 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wysenski Nancy CENTRAL INDEX KEY: 0001294596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 201370339 MAIL ADDRESS: STREET 1: 2200 SUNBURST STREET CITY: CHATSWORTH STATE: CA ZIP: 90401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-12-02 0001520262 Alkermes plc. ALKS 0001294596 Wysenski Nancy CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Non Qualified Stock Option (Right to Buy) 18.82 2020-12-02 4 A 0 11509 0 A 2021-12-02 2030-12-02 Ordinary Shares 11509 11509 D Restricted Stock Unit Award 0 2020-12-02 4 A 0 5578 0 A 2021-12-02 Ordinary Shares 5578 5578 D This option becomes exercisable in full on 12/2/2021. Shares subject to the restricted stock unit award vest in full on 12/2/2021. /s/ Shantale Greenson, attorney-in-fact for Nancy J. Wysenski 2020-12-04